Elon Musk's SpaceX Stock Just Closed Above Its $135 IPO Price for the First Time in Weeks. Is the Rebound a Buy Signal?

SpaceX’s Q2 results on Aug. 4 helped shares rebound, with revenue up 92% YoY to $7.8B and net loss narrowing to $541M. AI revenue surged to $2.6B (from $737M), supporting investor optimism and highlighting the Terafab AI-chip JV with Tesla. However, the stock is described as expensive (P/S >90 vs Nvidia ~22) and large upcoming share unlocks (~700M shares in Sep/Oct) could pressure the price, making entry timing less clear.

Analysis

The tradeable issue is not the latest quarter; it is the mismatch between a high-multiple story and an expanding public float. When a newly listed name rerates on one strong print, the marginal buyer is usually momentum capital, and that capital tends to exit quickly once scheduled unlocks increase supply. That creates a setup where the stock can leak lower even if fundamentals are merely good, because the market needs repeated proof to justify a valuation that already assumes near-perfect execution.

Over the next 1-3 months, the lockup/unlock calendar is the key catalyst, not the business narrative. If insider selling or secondary supply meets weaker breadth in the AI trade, the multiple can compress sharply before any real fundamental deterioration shows up. The more important 6-18 month question is whether the AI spend is translating into equity value or just prepaying for growth that accrues to suppliers and partners; until there is durable free-cash-flow conversion, the equity remains vulnerable to a de-rating.

The consensus is missing that the cleanest beneficiary of this spend is likely the semiconductor and infrastructure stack, not the company taking the capex risk. For investors who want AI exposure, NVDA or SMH is the cleaner expression; for investors looking to fade enthusiasm, SPCX is the crowded part of the trade. The thesis would be falsified if the stock absorbs unlock supply, holds above the post-earnings breakout area, and management prints two consecutive quarters of accelerating margins and cash flow.

Key Decisions for Investors

• Initiate a 1-2 month bearish expression in SPCX via put spreads into the September/October unlock window; target ~20-30% downside with defined risk, and cover if the stock holds its post-earnings breakout level after supply comes through.
• Run a relative-value pair: long NVDA or SMH vs short SPCX over the next 3-6 months to express 'credible AI monetization vs narrative premium'; exit the short leg if SPCX demonstrates sustained free-cash-flow inflection and repeated margin expansion.
• Do not chase TSLA on the Terafab angle yet; treat it as a watch item only. The joint-venture narrative is more likely to add execution risk and capex pressure than near-term earnings upside unless there is evidence of external customer demand.
• Set an alert for any secondary offering, insider distribution, or unusually heavy volume around unlock dates; if supply is absorbed with no follow-through decline, the bearish setup is likely exhausted and should be reduced.